Thursday, January 31, 2019 Daily Archives

Hitachi brings cell therapy biz to Europe through $86m apceth buy

by

Hitachi Chemical will add two production plants and 600m2 of cleanroom through the acquisition of German cell therapy manufacturing firm apceth Biopharma. The deal, expected to close in April, sees Japanese firm Hitachi acquire all shares of apceth for JPY 9.4 billion ($86 million) from Santo Holding GmbH, FCP Biotech Holding GmbH and other individual shareholders. apceth has around 120 employees operating from its site in Munich, Germany. The site includes two GMP/BSL2 cell and gene therapy production facilities, including…

January 31, 2019

Samsung BioLogics to double utilization of 3rd plant by end of year

by

Three months after production began at its 180,000 L facility, CDMO Samsung BioLogics says it has filled 25% of its capacity. In October 2018, South Korean contract development and manufacturing organization (CDMO) Samsung BioLogics started commercial production at its third facility located at its Songdo, Incheon site. The plant has been touted as the world’s largest single biomanufacturing facility, boasting 180,000 L of capacity from 12 15,000 L stainless steel tanks, and according to Samsung BioLogics’ 2018 results, it is…

January 31, 2019